Annexon Bioscience Receives $34,000,000 Series A Funding Round

  • Feed Type
  • Date
    12/16/2014
  • Company Name
    Annexon Bioscience
  • Mailing Address
    Undisclosed Redwood City, CA 94062 USA
  • Company Description
    Annexon is developing novel therapeutics for neurodegenerative and autoimmune disorders. We have discovered that early components of the classical complement cascade accumulate on synapses with normal aging and are activated as the brain encounters stress or disease to cause loss of nerve connections.
  • Website
    http://www.annexonbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $34,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company intends to use the funds for the development of its lead candidate, ANX005, for the treatment of neurodegenerative and autoimmune disorders.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy